Analytical Data
-
基因名
USP52
- Application
-
别名
KIAA0710; USP52
-
种属
Human
-
表达系统
Baculovirus
-
标签
His;GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q504Q3-1
-
表达区间
M486-R924
-
蛋白长度
Partial
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
USP52, a member of the ubiquitin-specific protease family, plays a crucial role in regulating protein degradation and cellular homeostasis by deubiquitinating target proteins. The dysregulation of deubiquitinases like USP52 has been implicated in various diseases, including cancer, neurodegenerative disorders, and immune dysfunctions. Research has shown that USP52 can influence critical cellular processes such as signal transduction, cell cycle progression, and apoptosis, making it a potential therapeutic target. Additionally, studies indicate that USP52 interacts with key signaling pathways, including the PI3K/Akt and NF-κB pathways, further emphasizing its importance in modulating cellular responses to stress and inflammation. Given its pivotal role in these physiological and pathological processes, understanding the mechanisms underlying USP52 function and regulation is essential for developing novel strategies for therapeutic intervention. Ongoing investigations into the structural and functional characterization of USP52, coupled with advancements in proteomic and genomic technologies, aim to delineate its specific substrates and regulatory mechanisms. This research not only contributes to the fundamental knowledge of ubiquitin-mediated signaling but also holds promise for identifying biomarkers and therapeutic targets in cancer and other diseases associated with aberrant ubiquitination.












